Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
Jai Rautela, Nikola Baschuk, Clare Y Slaney, Krishnath M Jayatilleke, Kun Xiao, Bradley N Bidwell, Erin C Lucas, Edwin D Hawkins, Peter Lock, Christina S Wong, Weisan Chen, Robin L Anderson, Paul J Hertzog, Daniel M Andrews, Andreas Moeller, Belinda S Parker
Cancer Immunology Research | AMER ASSOC CANCER RESEARCH | Published : 2015
Awarded by National Breast Cancer Foundation
This work was supported by grant funding from the Cancer Council Victoria (to B.S. Parker and P.J. Hertzog), the National Health and Medical Research Council (NHMRC; to B.S. Parker and P.J. Hertzog), fellowship support from NHMRC and ARC (to B.S. Parker and P.J. Hertzog), and the National Breast Cancer Foundation [NBCF; fellowships to CYS (co-funded by Cure Cancer Australia), R.L. Anderson, and A. Moller].